2Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum, 1988, 31:315-324.
3Goldring SR, Gravallese EM. Mechanisms of bone loss inflammatory arthritis: diagnosis and therapeutic implications. Arthritis Res, 2000, 2: 33-37.
4Haugeberg G, Orstavik RE, Kvien TK. Effects of rheumatoid arthritis on bone. Curr Opin Rheumatol, 2003, 15: 469-475.
5Yasuda H, Shima N, Nakagawa N, et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastgensis inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA, 1998, 95: 3597-3602.
6Romoas E, Bakharevski O, Hards D, et al. Expression of osteoclast differentiation factor at site of bone erosion in collagen induced arthritis. Arthritis Rheum, 2000, 43: 821-826.
7Lorenz C, Armin E, Reinhold G. OPG, RANK, and RANKL: the good, bad, and the ugly in rheumatoid arthritis. J Rheumatol,2001, 28: 685-687.
8Shibuya K, Hagino H, Morio Y, et al. Cross-sectional and longitudinal study of osteoporosis in patients with rheumatoid arthritis.Clin Rheumatol, 2002, 21: 150-158.
9Madsen OR, Sorensen OH, Egsmose C. Bone quality and bone mass as assessed by quantitative ultrasound and dual energy X-ray absorptiometry in women with rheumatoid arthritis: relationship with quadricep strength. Ann Rheum Dis. 2002, 61: 325-329.
10Haugeberg G, Orstavik R, Uhlig T, et al. Bone loss in patients with rheumatoid arthritis: results from a population based cohort of 366 patients followed over 2 years. Arthritis Rheum, 2002, 46:1721-1728.
